+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Tumor Ablation Market, by Treatment, by Technology, by Application, by Country, Industry Analysis and Forecast, 2019 - 2025

  • PDF Icon

    Report

  • 97 Pages
  • February 2020
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5006135
The Europe Tumor Ablation Market is expected to witness market growth of 10% CAGR during the forecast period (2019-2025).

The factors projected to accelerate the demand for advanced tumor ablation technologies over the forecast period include increased inclination of surgeons and patients towards minimally invasive procedures due to benefits such as speedy recovery, patient satisfaction, and lowered turnaround time. Advanced treatments for tumor ablation are generally performed on an outpatient basis and do not involve hospital admission compared to traditional therapies. This also significantly reduces the overall healthcare cost.

One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.

The ongoing technological advancements have made tumor ablation treatment a safe and painless one especially due to impressive results during and after the procedure. With increasing awareness in the healthcare industry around the world, cancer ablation is becoming increasingly popular for different types of cancer as one of the most favored cancer therapy methods. Hospitals and healthcare centers are recognizing the immense potential of cancer ablation therapy, thereby supporting their patients with the facility that is expected to further assist in facilitating the therapeutic.

Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.

Scope of the Study

Market Segmentation:

By Treatment
  • Surgical Ablation
  • Laparoscopic Ablation and
  • Percutaneous Ablation

By Technology
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation and
  • Other Technology

By Application
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer and
  • Other Cancer

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Medtronic PLC
  • Johnson and Johnson (Ethicon, Inc.)
  • Boston Scientific Corporation
  • Misonix, Inc.
  • EDAP TMS S.A.
  • Theraclion SA
  • AngioDynamics, Inc.
  • Mermaid Medical A/S
  • HealthTronics, Inc. (Altaris Capital Partners, LLC)
  • SonaCare Medical, LLC

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tumor Ablation Market, by Treatment
1.4.2 Europe Tumor Ablation Market, by Technology
1.4.3 Europe Tumor Ablation Market, by Application
1.4.4 Europe Tumor Ablation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : Jan 2016 - Oct 2019) Leading Players
Chapter 4. Europe Tumor Ablation Market by Treatment
4.1 Europe Surgical Ablation Market by Country
4.2 Europe Laparoscopic Ablation Market by Country
4.3 Europe Percutaneous Ablation Market by Country
Chapter 5. Europe Tumor Ablation Market by Technology
5.1 Europe Radiofrequency Ablation Market by Country
5.2 Europe Microwave Ablation Market by Country
5.3 Europe Cryoablation Market by Country
5.4 Europe Irreversible Electroporation Market by Country
5.5 Europe Other Technology Market by Country
Chapter 6. Europe Tumor Ablation Market by Application
6.1 Europe Liver Cancer Market by Country
6.2 Europe Breast Cancer Market by Country
6.3 Europe Lung Cancer Market by Country
6.4 Europe Kidney Cancer Market by Country
6.5 Europe Prostate Cancer Market by Country
6.6 Europe Others Cancer Market by Country
Chapter 7. Europe Tumor Ablation Market by Country
7.1 Germany Tumor Ablation Market
7.1.1 Germany Tumor Ablation Market by Treatment
7.1.2 Germany Tumor Ablation Market by Technology
7.1.3 Germany Tumor Ablation Market by Application
7.2 UK Tumor Ablation Market
7.2.1 UK Tumor Ablation Market by Treatment
7.2.2 UK Tumor Ablation Market by Technology
7.2.3 UK Tumor Ablation Market by Application
7.3 France Tumor Ablation Market
7.3.1 France Tumor Ablation Market by Treatment
7.3.2 France Tumor Ablation Market by Technology
7.3.3 France Tumor Ablation Market by Application
7.4 Russia Tumor Ablation Market
7.4.1 Russia Tumor Ablation Market by Treatment
7.4.2 Russia Tumor Ablation Market by Technology
7.4.3 Russia Tumor Ablation Market by Application
7.5 Spain Tumor Ablation Market
7.5.1 Spain Tumor Ablation Market by Treatment
7.5.2 Spain Tumor Ablation Market by Technology
7.5.3 Spain Tumor Ablation Market by Application
7.6 Italy Tumor Ablation Market
7.6.1 Italy Tumor Ablation Market by Treatment
7.6.2 Italy Tumor Ablation Market by Technology
7.6.3 Italy Tumor Ablation Market by Application
7.7 Rest of Europe Tumor Ablation Market
7.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.7.2 Rest of Europe Tumor Ablation Market by Technology
7.7.3 Rest of Europe Tumor Ablation Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview

Companies Mentioned

  • Medtronic PLC
  • Johnson and Johnson (Ethicon, Inc.)
  • Boston Scientific Corporation
  • Misonix, Inc.
  • EDAP TMS S.A.
  • Theraclion SA
  • AngioDynamics, Inc.
  • Mermaid Medical A/S
  • HealthTronics, Inc. (Altaris Capital Partners, LLC)
  • SonaCare Medical, LLC

Methodology

Loading
LOADING...